143 results on '"Thourani, Vinod H."'
Search Results
2. Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort
3. 2023 ACC/AHA/SCAI Advanced Training Statement on Interventional Cardiology (Coronary, Peripheral Vascular, and Structural Heart Interventions): A Report of the ACC Competency Management Committee
4. The Mortality Burden of Untreated Aortic Stenosis
5. Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation
6. UNTREATED AORTIC STENOSISMORTALITY BY DIAGNOSIS SEVERITY: RESULTS FROM A LARGE REAL-WORLD DATABASE
7. TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT FOR STENOTIC BICUSPID AORTIC VALVE: A SYSTEMATIC REVIEW AND META-ANALYSIS
8. PROGNOSTIC IMPACT OF CARDIAC DAMAGE ACROSS THE SPECTRUM OF AORTIC STENOSIS SEVERITY:RESULTS FROM A LARGE REAL-WORLD DATABASE
9. Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials
10. Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair
11. Risk of Surgical Mitral Valve Repair for Primary Mitral Regurgitation
12. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement
13. Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement
14. TAVR Sustains Its Promise in Low-Risk Patients, But the Journey Is Far From Over
15. COMPARING VOLUME VERSUS QUALITY THRESHOLDS ON OUTCOMES AND ACCESS TO TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN THE UNITED STATES: INSIGHTS FROM THE TVT REGISTRY
16. HEART TEAM IS EVEN MORE CRITICAL WHEN DEALING WITH UNIQUE CLINICAL CONDITIONS: SUCCESSFUL PERCUTANEOUS INTERVENTION OF BILATERAL PULMONARY ARTERY STENOSIS AS A TREATMENT FOR SEVERE TRICUSPID REGURGITATION
17. DECREASED RIGHT VENTRICULAR FREE WALL STRAIN PREDICTS INCREASED MORTALITY EVEN IN THE SETTING OF NORMAL FRACTIONAL AREA CHANGE, TRICUSPID ANNULAR PLANE EXCURSION, AND NORMAL RIGHT VENTRICULAR SIZE IN PATIENTS WITH GREATER THAN MODERATE TRICUSPID REGURGITATION
18. AUTOMATIC MEASUREMENT OF AORTIC STRUCTURES USING ARTIFICIAL INTELLIGENCE FOR PRE-PROCEDURAL EVALUATION OF TAVR PATIENTS
19. TRICUSPID REGURGITATION DISEASE PROGRESSION AND MACHINE LEARNING-BASED CLUSTER ANALYSIS OF GREATER THANMODERATE TRICUSPID REGURGITATION REVEALS DISTINCT POPULATION WITH DIFFERENT PHENOTYPES AND CLINICALOUTCOMES
20. COMPUTATIONAL MODELING OF CORONARY OBSTRUCTION IN VALVE-IN-VALVE TAVR: CHOOSING THE RIGHT VIRTUAL VALVE TO CORONARY DISTANCE
21. Aortic Valve Replacement and Patient-Centered Implementation
22. 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation
23. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership
24. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk
25. Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation
26. 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease
27. Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement
28. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement
29. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial
30. Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement
31. Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease
32. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement
33. TAVR in TAVR
34. PERIPHERAL VERSUS CENTRAL ACCESS FOR ALTERNATIVE ACCESS TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): RESULTS FROM THE TVT REGISTRY
35. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
36. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
37. Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease
38. Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation
39. Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses
40. 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement
41. Prosthesis–Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement
42. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
43. Is Off-Pump CABG Off Base?
44. Transcatheter Aortic Valve Replacement of Failed Surgically Implanted Bioprostheses
45. IMPACT AND PREDICTORS OF PARAVALVULAR REGURGITATION FOLLOWING IMPLANTATION OF THE FULLY REPOSITIONABLE AND RETRIEVABLE LOTUS TRANSCATHETER AORTIC VALVE: RESULTS FROM THE REPRISE III RANDOMIZED CONTROLLED TRIAL
46. OUTCOMES AND SOCIETY OF THORACIC SURGEONS RISK SCORE: A SUBANALYSIS OF THE REPRISE III RANDOMIZED CLINICAL TRIAL
47. REDUCED BASELINE EJECTION FRACTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR MORTALITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER II TRIALS
48. NEW PACEMAKER IMPLANTATION AFTER SURGICAL AORTIC VALVE REPLACEMENT IN THE PARTNER TRIALS: RATES, RISK FACTORS, AND CLINICAL OUTCOMES
49. CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH PRIOR CHEST RADIATION UNDERGOING TAVR: OBSERVATIONS FROM THE PARTNER 2 TRIAL AND REGISTRIES
50. HIGH HOSPITAL VARIABILITY IN MORTALITY AFTER TAVR CAN BE EXPLAINED BY DIFFERENCES IN FAILURE TO RESCUE FROM POST PROCEDURAL COMPLICATIONS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.